GLSI
Greenwich Lifesciences Inc
Price:  
8.95 
USD
Volume:  
71,770.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GLSI WACC - Weighted Average Cost of Capital

The WACC of Greenwich Lifesciences Inc (GLSI) is 5.7%.

The Cost of Equity of Greenwich Lifesciences Inc (GLSI) is 7.80%.
The Cost of Debt of Greenwich Lifesciences Inc (GLSI) is 5.00%.

Range Selected
Cost of equity 6.20% - 9.40% 7.80%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 4.9% - 6.5% 5.7%
WACC

GLSI WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.5 0.82
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.20% 9.40%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 4.9% 6.5%
Selected WACC 5.7%